BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MagStar Technologies Announces New Blanket Order With Haemonetics Corporation


10/19/2005 5:11:56 PM

HOPKINS, Minn., Oct. 25 /PRNewswire-FirstCall/ -- MagStar Technologies, Inc. ("MagStar") (BULLETIN BOARD: MGST) has been awarded a blanket order to supply Haemonetics Corporation with medical centrifuges for processing blood. These centrifuges are used in medical devices that collect and clean blood lost by a patient during surgery so that the blood is available for transfusion back to the patients undergoing higher blood loss surgeries. MagStar has been a contract manufacturer of centrifuges for Haemonetics for over 12 years.

Haemonetics is a world leader in the automated processing of blood. To support its large, global customer base, Haemonetics produces a steady stream of surgical blood salvage devices that use the MagStar Centrifuge. This new contract will support that production process.

More information on the companies may be found at their websites http://www.magstar.com/ and http://www.haemonetics.com/ .

MagStar is a publicly owned company that trades under the symbol "MGST" on the Over The Counter Bulletin Board market. MagStar divides sales into the following core competencies: Medical, Magnets, Industrial, Contract Manufacturing, and Conveyors/Factory Automation. For over 10 years, ISO-certified MagStar Technologies, Inc. has been a trusted medical device supplier, using its expertise in centrifuge and medical device design and manufacturing, by partnering its engineers and salespeople with well-known, national OEM's. MagStar's expertise in oil centrifuges includes manufacturing for internationally prominent engine OEMs with 12 years of history designing, engineering, and manufacturing oil centrifuges to meet market and emissions requirements. MagStar's expertise in factory automation and conveyors includes serving national and international based high-tech OEMs. MagStar has a patented product line that evolves with industry requirements, including the recent introduction of a patented clean room conveyor. MagStar has over 10 years of history designing, engineering, and manufacturing magnet assemblies to meet the exacting requirements of our customers.

The information in this discussion may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties, including statements regarding the Company's capital needs, business strategy and expectations. Any statements that are not of historical fact may be deemed to be forward-looking statements. These forward-looking statements involve substantial risks and uncertainties. In some cases you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "intend," "anticipate," "believe," "estimate," "predict," "potential," or "continue," the negative of the terms or other comparable terminology. Forward-looking statements in this Report also include references to anticipated sales volume and product margins, efforts aimed at establishing new or improving existing relationships with customers, other business development activities, anticipated financial performance, business prospects and similar matters. Actual events or results may differ materially from the anticipated results or other expectations expressed in the forward-looking statements. In evaluating these statements, you should consider various factors, including the risks included from time to time in other reports or registration statements filed with the United States Securities and Exchange Commission. These factors may cause the Company's actual results to differ materially from any forward-looking statements. The Company disclaims any obligation to publicly update these statements, or disclose any difference between actual results and those reflected in these statements. Such information constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 which provides a safe harbor for forward looking statements. For more information, please contact Jon L. Reissner, President and Chief Executive Officer, at 952-935-6921.

MagStar Technologies, Inc.

CONTACT: Jon L. Reissner, President and Chief Executive Officer ofMagStar Technologies, Inc., +1-952-935-6921



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->